Basic Information
Gabapentin
68788-7757
Regulatory Information
68788-7757
ANDA205101
C73584
June 29, 2023
USA
These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
HUMAN PRESCRIPTION DRUG LABEL
4
Company Information
791119022
Active Ingredients
POLOXAMER 407
Code: TUF2IVW3M2
Class Code: IACT
MANNITOL
Code: 3OWL53L36A
Class Code: IACT
MAGNESIUM STEARATE
Code: 70097M6I30
Class Code: IACT
CROSPOVIDONE
Code: 2S7830E561
Class Code: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIED
Code: 9XZ8H6N6OH
Class Code: IACT
COPOVIDONE K25-31
Code: D9C330MD8B
Class Code: IACT
TALC
Code: 7SEV7J4R1U
Class Code: IACT
SILICON DIOXIDE
Code: ETJ7Z6XBU4
Class Code: IACT
POLYETHYLENE GLYCOL, UNSPECIFIED
Code: 3WJQ0SDW1A
Class Code: IACT
HYPROMELLOSE, UNSPECIFIED
Code: 3NXW29V3WO
Class Code: IACT
TITANIUM DIOXIDE
Code: 15FIX9V2JP
Class Code: IACT
Active Moieties
GABAPENTIN
Code: 6CW7F3G59X